Search for: "GlaxoSmithKline LLC"
Results 161 - 180
of 181
Sort by Relevance
|
Sort by Date
23 Apr 2010, 8:20 am
., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research Institute, U.S. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV… [read post]
28 Mar 2010, 8:33 pm
• Defendants: Glaxosmithkline LLC; Glaxo Group Ltd. [read post]
26 Mar 2010, 7:23 am
Further, the Staff Report mischaracterizes and distorts the efforts that GlaxoSmithKline LLC (“GSK”) took to continue to monitor the safety and efficacy of its diabetes medication. [read post]
25 Jan 2010, 5:00 am
S & M NuTec LLC, 245 F.R.D. 429, 438 (C.D. [read post]
19 Oct 2009, 1:24 am
The ruling wipes out verdicts of $33 million against Novartis, $81 million against GlaxoSmithKline, and $215 million (reduced post-trial to $160 million) against AstraZeneca. [read post]
14 Oct 2009, 1:42 am
Glaxo Hit With $2.5 Million Jury Verdict in Paxil Test Case
The American Lawyer
A Philadelphia jury found Tuesday that GlaxoSmithKline failed to properly warn doctors and pregnant women about risks associated with its blockbuster antidepressant Paxil. [read post]
12 Oct 2009, 12:29 am
"IPKat readers will recall that GlaxoSmithKline (and later joined by other biotech companies and universities) challenged the previous rules in 2007 in federal court. [read post]
1 Oct 2009, 2:14 am
GlaxoSmithKline PLC, 2008 WL 2247067 (E.D. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb) Biotechnology… [read post]
3 Aug 2009, 6:18 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
21 Jul 2009, 6:56 am
The GlaxoSmithKline Poligrip Defendants (SmithKline Beecham Corp., GlaxoSmithKline Consumer Healthcare LLC, GlaxoSmithKline Consumer Healthcare, LP, and Block Drug Company, Inc.) supported the Plaintiffs' motion for consolidation, while the Proctor and Gamble Fixodent Defendants (The Procter & Gamble Manufacturing Co. and The Procter & Gamble Distributing LLC) opposed consolidation. [read post]
3 Apr 2009, 1:05 am
The opinion follows a similar recent 5th Circuit ruling in which the court upheld summary judgment for Paxil maker GlaxoSmithKline on learned intermediary grounds. [read post]
25 Jan 2009, 2:36 pm
" Wyeth also has "plenty of lingering legal and patent expiration problems of its own," said Carol Levenson, an analyst with Gimme Credit LLC in Chicago, in a Jan. 23 note to clients. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical… [read post]
31 Oct 2007, 11:39 am
This morning, GlaxoSmithKline prevailed in the District Court for the Eastern District of Virginia and succeeded at enjoining the USPTO from making the Final Rules on claims and continuations effective. [read post]
6 Sep 2007, 8:13 am
GlaxoSmithKline, 484 F. [read post]
